Brown & Brown (NYSE:BRO) is now covered by analysts at Argus. They set a "buy" rating and a $120.00 price target on the stock. This represents a 17.1% upside from the current price of $102.49. |
Maplebear (NASDAQ:CART) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $39.74. |
Church & Dwight (NYSE:CHD) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $120.00 price target on the stock. This represents a 15.9% upside from the current price of $103.53. |
Colgate-Palmolive (NYSE:CL) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $121.00 price target on the stock. This represents a 16.7% upside from the current price of $103.72. |
DoorDash (NASDAQ:DASH) is now covered by analysts at Raymond James. They set an "outperform" rating and a $155.00 price target on the stock. This represents a 10.2% upside from the current price of $140.63. |
Dayforce (NYSE:DAY) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 16.1% upside from the current price of $60.30. |
DiDi Global (NYSE:DIDIY) is now covered by analysts at Macquarie. They set an "outperform" rating and a $5.50 price target on the stock. This represents a 35.8% upside from the current price of $4.05. |
EHang (NASDAQ:EH) is now covered by analysts at China Renaissance. They set a "buy" rating on the stock.The current price is $12.84. |
FibroBiologics (NASDAQ:FBLG) is now covered by analysts at Maxim Group. They set a "buy" rating and a $12.00 price target on the stock. This represents a 313.8% upside from the current price of $2.90. |
GE Vernova (NYSE:GEV) is now covered by analysts at Guggenheim. They set a "buy" rating and a $300.00 price target on the stock. This represents a 17.3% upside from the current price of $255.75. |
Kenvue (NYSE:KVUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 17.3% upside from the current price of $23.01. |
Lipocine (NASDAQ:LPCN) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $10.00 price target on the stock. This represents a 108.3% upside from the current price of $4.80. |
Lyft (NASDAQ:LYFT) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $13.16. |
National Health Investors (NYSE:NHI) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $92.00 price target on the stock. This represents a 8.8% upside from the current price of $84.54. |
Procore Technologies (NYSE:PCOR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $73.00 price target on the stock. This represents a 19.1% upside from the current price of $61.28. |
Procter & Gamble (NYSE:PG) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $174.00 price target on the stock. This represents a 0.2% upside from the current price of $173.58. |
Pinterest (NYSE:PINS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $45.00 price target on the stock. This represents a 44.8% upside from the current price of $31.07. |
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $65.00 price target on the stock. This represents a 40.2% upside from the current price of $46.37. |
ResMed (NYSE:RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock. This represents a 13.3% upside from the current price of $247.23. |
Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $59.00 price target on the stock. This represents a 34.1% upside from the current price of $43.99. |
Sky Harbour Group (NYSEAMERICAN:SKYH) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $16.00 price target on the stock. This represents a 25.4% upside from the current price of $12.76. |
TransMedics Group (NASDAQ:TMDX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $200.00 price target on the stock. This represents a 25.8% upside from the current price of $158.93. |
Uber Technologies (NYSE:UBER) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock. This represents a 17.3% upside from the current price of $76.73. |
Valaris (NYSE:VAL) is now covered by analysts at Susquehanna. They set a "neutral" rating and a $62.00 price target on the stock. This represents a 9.6% upside from the current price of $56.59. |
Zevra Therapeutics (NASDAQ:ZVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 112.5% upside from the current price of $8.00. |
No comments:
Post a Comment